Literature DB >> 14658400

[A case of acute cholinergic adverse effects induced by donepezil overdose: a follow-up of clinical course and plasma concentration of donepezil].

Hidetaka Yano1, Yoko Fukuhara, Kenji Wada, Hisanori Kowa, Kenji Nakashima.   

Abstract

A 79-year-old woman with Alzheimer's disease was admitted due to acute cholinergic symptoms induced by overdose (45 mg) of donepezil (DPZ). Physical examination showed bradycardia, sinus arrhythmia, vomiting and respiratory insufficiency. She was treated with atropine intravenously and her cholinergic symptoms subsided in the next evening. After 5 days she was discharged from the hospital and DPZ was withholded for about 4 weeks. The plasma concentration of DPZ was 54.6 ng/ml on admission and gradually decreased to the normal limits in about 90 hours. The calculative half-life of DPZ was about 55 hours. Since the half-life of DPZ is long and differs between individuals, hospitalization and treatment with atropine is recommended for cholinergic side effects induced by overdose of DPZ. It is important to prevent dosing errors in cooperation with medical providers, patients and families.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14658400

Source DB:  PubMed          Journal:  Rinsho Shinkeigaku        ISSN: 0009-918X


  2 in total

1.  Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer's Disease.

Authors:  Thomas N Chase; Martin R Farlow; Kathleen Clarence-Smith
Journal:  Neurotherapeutics       Date:  2017-04       Impact factor: 7.620

2.  Effects of different administration protocols on the plasma concentration of donepezil hydrochloride in dementia patients with stage 5 chronic kidney disease.

Authors:  Chika Amano; Takafumi Ito; Masahiro Egawa; Tomohiro Oka; Ken Hanada; Kosuke Matsui; Toru Nabika; Kazuaki Tanabe
Journal:  Nephron Extra       Date:  2013-06-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.